incorporating novel agents for myelofibrosis in the pre- and post-transplant settings
Published 1 year ago • 123 plays • Length 1:56Download video MP4
Download video MP3
Similar videos
-
3:24
novel agents for the management of r/r myeloma
-
1:07
advances in the treatment of myelofibrosis & the role of transplantation in this space
-
2:00
novel treatment strategies in myelofibrosis
-
3:23
novel drugs and treatment strategies for myelofibrosis
-
1:15
exploring the evolving treatment landscape of myelofibrosis
-
1:49
managing treatment toxicities when developing novel agents for mpns
-
4:10
the management of prefibrotic myelofibrosis
-
3:54
an insight into how novel agents are influencing survival outcomes in patients with mf
-
2:55
impactmf: imetelstat vs best available therapy in patients with myelofibrosis
-
4:36
being marilyn…with myelofibrosis—an mf journey
-
4:36
living in the moment with myelofibrosis—david’s mf journey
-
1:28
comorbidities and treatment decisions in myelofibrosis
-
3:19
first-line treatment selection in myelofibrosis
-
1:36
the role of molecular markers in patient selection for transplantation in myelofibrosis
-
2:41
novel therapies for myelofibrosis
-
2:13
exciting agents and treatment approaches emerging in the field of myelofibrosis
-
1:04
exciting updates in mf: novel targets and agents
-
1:33
the need for novel therapeutic agents in myeloproliferative neoplasms
-
1:31
promising agents under investigation for the treatment of myelofibrosis with cytopenia
-
2:52
jak inhibitor combination therapy for the treatment of myelofibrosis
-
1:58
novel myelofibrosis-associated anemia treatments in phase ii trials
-
1:31
novel treatment agents and how they're changing the mpn field